He noted that trials that combine neuroimaging techniques that measure the blood-brain barrier and GLP-1 treatment are needed and could prove that these drugs have neuroprotective benefits.
Background: Bipolar disorders (BD) are severe mental illnesses that are often misdiagnosed ... To be eligible, all participants were: (1) aged between 12 and 18 years; (2) diagnosed with a BD ...
More recently, it has been explored as an adjunctive treatment for bipolar 1 depression. Some evidence indicates that modafinil can significantly improve depressive symptoms and functioning in ...